Steven Cohen Biomarin Pharmaceutical Inc Transaction History
Point72 Asset Management, L.P.
- $42.2 Billion
- Q4 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 266,436 shares of BMRN stock, worth $17.5 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
266,436
Previous 197,718
34.76%
Holding current value
$17.5 Million
Previous $13.9 Million
26.01%
% of portfolio
0.04%
Previous 0.04%
Shares
24 transactions
Others Institutions Holding BMRN
# of Institutions
626Shares Held
183MCall Options Held
2MPut Options Held
1.67M-
Black Rock Inc. New York, NY22.7MShares$1.49 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.4MShares$1.27 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA18.2MShares$1.19 Billion0.94% of portfolio
-
Dodge & Cox San Francisco, CA14.7MShares$968 Million0.61% of portfolio
-
Capital Research Global Investors Los Angeles, CA13MShares$852 Million0.18% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $12.2B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...